Our top pick for
Garrett Motion Inc is an auto parts business based in the US. Garrett Motion shares (GTX) are listed on the NASDAQ and all prices are listed in US Dollars. Garrett Motion employs 6,300 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.41|
|52-week range||$2.60 - $8.90|
|50-day moving average||$7.19|
|200-day moving average||$6.94|
|Wall St. target price||$15.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.93|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||3.64%|
|1 month (2021-09-24)||3.06%|
|3 months (2021-07-23)||3.35%|
|6 months (2021-04-23)||46.73%|
|1 year (2020-10-23)||126.61%|
|2 years (2019-10-24)||-20.66%|
|3 years (2018-10-24)||13.77|
|5 years (2016-10-20)||N/A|
Valuing Garrett Motion stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Garrett Motion's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Garrett Motion's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Garrett Motion shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Garrett Motion's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $555 million.
The EBITDA is a measure of a Garrett Motion's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.7 billion|
|Operating margin TTM||12.26%|
|Gross profit TTM||$566 million|
|Return on assets TTM||11.7%|
|Return on equity TTM||0%|
|Market capitalisation||$465.2 million|
TTM: trailing 12 months
There are currently 2.5 million Garrett Motion shares held short by investors – that's known as Garrett Motion's "short interest". This figure is 11.7% up from 2.3 million last month.
There are a few different ways that this level of interest in shorting Garrett Motion shares can be evaluated.
Garrett Motion's "short interest ratio" (SIR) is the quantity of Garrett Motion shares currently shorted divided by the average quantity of Garrett Motion shares traded daily (recently around 297337.08920188). Garrett Motion's SIR currently stands at 8.52. In other words for every 100,000 Garrett Motion shares traded daily on the market, roughly 8520 shares are currently held short.
However Garrett Motion's short interest can also be evaluated against the total number of Garrett Motion shares, or, against the total number of tradable Garrett Motion shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Garrett Motion's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Garrett Motion shares in existence, roughly 40 shares are currently held short) or 0.0681% of the tradable shares (for every 100,000 tradable Garrett Motion shares, roughly 68 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Garrett Motion.
Find out more about how you can short Garrett Motion stock.
We're not expecting Garrett Motion to pay a dividend over the next 12 months.
Over the last 12 months, Garrett Motion's shares have ranged in value from as little as $2.6 up to $8.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Garrett Motion's is 2.1368. This would suggest that Garrett Motion's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Garrett Motion Inc. designs, manufactures, and sells turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers worldwide. The company offers light vehicle gasoline and diesel, and commercial vehicle turbochargers. It also provides automotive software solutions, such as automotive cybersecurity solutions, which include intrusion detection and prevention system (IDPS) and firewall, security operations center tools; integrated vehicle health management solutions; and vehicle diagnostic and prognostic solutions. The company offers its products in the aftermarket through distributors. Garrett Motion Inc. was incorporated in 2018 and is headquartered in Rolle, Switzerland.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.